Fetal gene therapy for neurodegenerative disease of infants

Journal: Nature Medicine

Published: 2018-07-16

DOI: 10.1038/s41591-018-0106-7

Affiliations: 17

Authors: 22

Go to article
Institutions FC
UCL Great Ormond Street Institute of Child Health (ICH), United Kingdom (UK) 0.14
Oxford Department of Pharmacology, United Kingdom (UK) 0.14
UCL Elizabeth Garret Anderson Institute for Women's Health, United Kingdom (UK) 0.11
NUS Department of Obstetrics and Gynecology, Singapore 0.11
UCL School of Pharmacy, United Kingdom (UK) 0.09
UCL Department of Neurodegenerative Disease, United Kingdom (UK) 0.09
Department of Basic and Clinical Neuroscience, KCL, United Kingdom (UK) 0.06
Institute of Reproductive and Developmental Biology (IRDB), ICL, United Kingdom (UK) 0.05
Division of Molecular Medicine and Gene Therapy, LU, Sweden 0.05
Department of Laboratory Medicine, GOSH, United Kingdom (UK) 0.05
Sanofi US, United States of America (USA) 0.05
Antiviral Gene Therapy Research Unit (AGTRU), South Africa 0.02
Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), United States of America (USA) 0.02
Edward Mallinckrodt Department of Pediatrics, WUSTL, United States of America (USA) 0.02
Department of Reproductive Medicine, KKH, Singapore 0.02
Duke-NUS Cancer and Stem Cell Biology Program (CSCB), Singapore 0.02